慢性阻塞性肺疾病生物标记物的研究进展(1)
[摘要] 慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是一种常见病和多发病,给患者和社会带来巨大的经济负担。肺功能试验是诊断慢阻肺的金标准,慢阻肺急性加重的诊断则主要根据临床表现,缺乏量化指标。血清生物标记物是一种定量指标,有助于慢阻肺急性加重的诊断,可指导治疗和预测预后。本文对最新发现的血清生物标记物作一综述。[关键词] 慢性阻塞性肺疾病;肺功能试验;急性加重;标记物
[中图分类号] R563.5 [文献标识码] A [文章编号] 1673-9701(2016)09-0159-04
[Abstract] Chronic obstructive pulmonary disease(COPD) is a common and frequently-occurring disease, which may lay a huge financial burden on the patients and the society. Respiratory function tests is the gold standard for the diagnosis of COPD ......
您现在查看是摘要页,全文长 4160 字符。